MANAGEMENT TEAM

James DeOlden, Esq. - Chief Executive Officer, Director
Mr. DeOlden, B.A. History (1996) from Virginia Commonwealth University J.D. (1998) from Whittier Law School, is an attorney admitted to the California Bar. Mr. DeOlden, in conjunction with being a founder of LifeStem International, Inc., maintains a minimum number of clients in his small law practice but is focused on the growth and development of LifeStem International, Inc. Mr. DeOlden currently represents or has represented both publicly traded and private companies, with the focus being on emerging growth companies in various stages of corporate existence or development.


Ed Deese - President, Chief Operating Officer, Director
Mr. Deese, B.S. Economics (1985) from the University of California, Irvine, has been involved in entrepreneurial business development for the past 17 years. Most recently, Mr. Deese has served in various interim capacities for publicly traded companies or subsidiaries thereof. Prior to this, Mr. Deese was a founder, Director, and Chief Operating Officer of Burstein Technologies, Inc., an Irvine, California bio-technology company. Prior to Burstein Technologies, Mr. Deese served in a variety of entrepreneurial ventures, including three companies that went public through IPOs.

SCIENTIFIC ADVISORY BOARD

Dr. Kary Mullis :: Nobel Laureate
Ph.D. Biochemistry, UC Berkeley
Dr. Mullis received the Nobel Prize in chemistry in 1993, for his invention of the polymerase chain reaction (PCR). The process, which Dr. Mullis conceptualized in 1983, is hailed as one of the monumental scientific techniques of the 20th century, one that revolutionized genetic science and engineering. PCR has also been an enormous commercial success. The original patent was sold to Hoffman LaRoche for $300 million and has generated more than a billion dollars in revenue from royalties.

Dr. David O'Bryan
Ph.D. Medical Sciences/Biochemistry, BU Med School
Dr. O'Bryan is a former Senior VP at SmithKline Beecham Clinical Laboratories. He has more than 28 years experience in the clinical testing industry, including significant experience in developing new technologies. On behalf of SmithKline Beecham Clinical Laboratories he negotiated license agreements involving patented gene sequences used to diagnose diseases and secured the first license for nucleic acid testing. Dr. O'Bryan is also a recognized expert in laboratory instrumentation and automation in the commercial reference laboratory industry.

Dr. Gerald Huth
Ph.D. Physics/Electronics, Uppsala University, Sweden
In 1985, Dr. Huth founded Xsirius Scientific, Inc. Two subsidiaries, Xsirius Superconductivity, Inc. and Xsirius Photonics, Inc. had IPOs and traded on NASDAQ, with Xsirius Scientific having a market cap exceeding $100 million.

Dr. Jason Van Tassel, M.D.
M.D., Georgetown University School of Medicine, Washington D.C.
Dr. Van Tassel is currently in medical practice specializing in Otolaryngology, Facial Plastic and Reconstructive Surgery in the San Francisco Bay area. Dr. Van Tassel attended Georgetown University School of Medicine in Washington D.C., graduating with Honors in 1997. Upon completion of his residency, Dr. Van Tassel joined the faculty at the University of California at Irvine in the Department of Facial Plastic and Reconstructive Surgery, completing a fellowship in 2003. He is currently board certified in Otolaryngology and board eligible in Facial Plastic and Reconstructive Surgery. Prior to practicing medicine in LA, Dr. Van Tassel worked at Hybritech Inc., where he performed research investigating manufacturing processes related to monoclonal antibody test assays. In addition, Dr. Van Tassel also investigated retinal signal transduction pathways for the Dept. of Neurosciences at San Diego State.


LSTM - Very Strong - Extremely Strong Buy $$$$$$$$$$$$$